(Q48794652)

15 February 2018

review article

1 reference

title

Methods of assessing the impact of climacteric complaints on quality of life. (English)

1 reference

15 February 2018

1 reference

Wiklund I

1

1 reference

15 February 2018

publication date

1 May 1998

1 reference

15 February 2018

published in

Maturitas

1 reference

15 February 2018

volume

29

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

41-50

1 reference

15 February 2018

State of science 1986: quality of life and functional status as target variables for research

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Methodologic problems in clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

The relationship between exercise tolerance and quality of life in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Psychosocial determinants of climacteric complaints.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Health status and utilization behavior associated with menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Are women using postmenopausal estrogens? A community survey

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Estrogen supplements in menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Prevalence and characteristics associated with use of hormone replacement therapy in Britain

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

12 Cost-effectiveness of hormone replacement therapy after the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Quality of life measures in health care. I: Applications and issues in assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Do psychological studies upset patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Quality of life assessment in clinical trials: methodologic issues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Factors of importance when evaluating quality of life in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Importance of sensitivity to change as a criterion for selecting health status measures

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Evaluation of quality of life in clinical trials. Selecting quality-of-life measures

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Relationships between psychological symptoms, somatic complaints and menopausal status

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Quality of life after the menopause: influence of hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A longitudinal study of the effects of menopause on sexuality

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A scale for the estimation of sleep problems in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

The McGill Pain Questionnaire: Major properties and scoring methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Causality, menopause, and depression: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A new methodological approach to the evaluation of quality of life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Quality of life measures in health care. II: Design, analysis, and interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A Swedish version of the Women's Health Questionnaire. A measure of postmenopausal complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A methodological framework for assessing health indices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Hormone profiles and psychological symptoms in peri-menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Perimenopausal sexuality

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Is sexual life influenced by transdermal estrogen therapy? A double blind placebo controlled study in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

The effects of antihypertensive therapy on the quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Perceived health: age and sex comparisons in a community

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

Menopause and perceived health status among the women of the French GAZEL cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

A quality of life perspective on who benefits from estradiol replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900027-9

7 January 2021

10.1016/S0378-5122(98)00027-9

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018